N-cadherin (Neural Cadherin, also known as Cadherin-2 or CDH2) is a calcium-dependent cell adhesion molecule critical for neuronal development, synaptic plasticity, and maintenance of neural circuits. As a classical cadherin, N-cadherin mediates homophilic adhesion between cells and plays essential roles in axonal guidance, synapse formation, and activity-dependent synaptic remodeling.
¶ Gene and Expression
The human CDH2 gene is located on chromosome 18q12.1 and encodes a transmembrane protein of 906 amino acids. Expression patterns include:
- Nervous system: Neurons, astrocytes, and Schwann cells
- Development: High expression during embryogenesis
- Adult brain: Maintained at synapses and in certain populations
- Non-neural tissues: Expressed in mesenchymal cells, endothelial cells
N-cadherin possesses a complex multi-domain architecture:
- Extracellular domain: Five cadherin repeats (EC1-EC5) for adhesion
- Calcium binding sites: Ca²⁺ between repeats maintains rigidity
- Transmembrane domain: Single-pass membrane-spanning helix
- Cytoplasmic domain: Connects to actin cytoskeleton via catenins
- C-terminal β-catenin binding site: Enables signaling functions
During neural development, N-cadherin regulates:
- Neurulation: Formation of the neural tube
- Axon guidance: Growth cone navigation and pathfinding
- Cell migration: Migration of neuronal precursors
- Cortex lamination: Layer formation in the cerebral cortex
- Synaptogenesis: Initial synapse formation between neurons
In mature neurons, N-cadherin modulates:
- Synapse stability: Maintains synaptic architecture
- LTP and LTD: Activity-dependent synaptic strengthening/weakening
- Spine morphology: Regulates dendritic spine shape
- Presynaptic differentiation: Induces presynaptic specializations
- Activity-dependent remodeling: Enables circuit refinement
N-cadherin mediates neuron-glia interactions:
- Axon-glial contacts: In peripheral nervous system
- Nodes of Ranvier: Organization of myelinated axons
- Astrocyte processes: Synaptic coverage by astrocytes
- Blood-brain barrier: Endothelial tight junctions
N-cadherin is implicated in AD pathogenesis:
- Amyloid interactions: Binds to amyloid-beta plaques
- Synaptic loss: Downregulation contributes to synapse elimination
- Tau pathology: Phosphorylation disrupts cadherin function
- Cognitive decline: Synaptic N-cadherin correlates with memory
- Therapeutic target: Stabilizing N-cadherin may protect synapses
In PD:
- Dopaminergic neurons: N-cadherin supports survival
- Axonal integrity: Maintains dopaminergic axon projections
- Synaptic function: Regulates synaptic vesicle cycling
- Potential therapy: N-cadherin mimetics under investigation
- Motor neuron degeneration: Altered expression in ALS
- Axonal transport: Affects cytoskeletal dynamics
- Glial involvement: Astrocytic N-cadherin in disease progression
- Schizophrenia: Altered N-cadherin expression
- Autism spectrum disorders: Genetic associations
- Depression: Stress-related changes
N-cadherin engages multiple intracellular signaling pathways:
- β-catenin: Transcriptional regulation and adhesion
- p120-catenin: Membrane stability and Rho GTPase regulation
- PI3K/Akt: Pro-survival signaling
- MAPK/ERK: Growth and differentiation
- Rho GTPases: Cytoskeletal dynamics
- Soluble N-cadherin: Detectable in CSF and blood
- Disease correlations: Altered levels in neurodegeneration
- Diagnostic utility: Under investigation
- Peptide mimetics: N-cadherin fragments for neuroprotection
- Antibody approaches: Targeting N-cadherin interactions
- Gene therapy: Modulating N-cadherin expression
- Functional antibodies: Blocking and activating antibodies
- Fusion proteins: Fc-N-cadherin for binding studies
- Peptides: Cell-permeable peptides for intracellular signaling
- Knockout mice: Embryonic lethal, revealing developmental roles
- Conditional knockouts: For tissue-specific deletion
- Mutant variants: Signaling-deficient mutants